161 related articles for article (PubMed ID: 20953176)
1. Efficient CNS gene delivery by intravenous injection.
Louboutin JP; Chekmasova AA; Marusich E; Chowdhury JR; Strayer DS
Nat Methods; 2010 Nov; 7(11):905-7. PubMed ID: 20953176
[TBL] [Abstract][Full Text] [Related]
2. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe.
Louboutin JP; Marusich E; Fisher-Perkins J; Dufour JP; Bunnell BA; Strayer DS
Gene Ther; 2011 Jul; 18(7):682-91. PubMed ID: 21368898
[TBL] [Abstract][Full Text] [Related]
4. Intracisternal rSV40 administration provides effective pan-CNS transgene expression.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Gene Ther; 2012 Jan; 19(1):114-8. PubMed ID: 21614027
[TBL] [Abstract][Full Text] [Related]
5. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.
Fu H; Muenzer J; Samulski RJ; Breese G; Sifford J; Zeng X; McCarty DM
Mol Ther; 2003 Dec; 8(6):911-7. PubMed ID: 14664793
[TBL] [Abstract][Full Text] [Related]
6. Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.
Strayer DS; Agrawal L; Cordelier P; Liu B; Louboutin JP; Marusich E; McKee HJ; Ren CN; Strayer MS
Mol Biotechnol; 2006 Oct; 34(2):257-70. PubMed ID: 17172671
[TBL] [Abstract][Full Text] [Related]
7. Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method.
Arad U; Zeira E; El-Latif MA; Mukherjee S; Mitchell L; Pappo O; Galun E; Oppenheim A
Hum Gene Ther; 2005 Mar; 16(3):361-71. PubMed ID: 15812231
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors.
Liu B; Daviau J; Nichols CN; Strayer DS
Blood; 2005 Oct; 106(8):2655-62. PubMed ID: 15994284
[TBL] [Abstract][Full Text] [Related]
10. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
[TBL] [Abstract][Full Text] [Related]
11. In vivo gene transfer to the CNS using recombinant SV40-derived vectors.
Louboutin JP; Agrawal L; Liu B; Strayer DS
Expert Opin Biol Ther; 2008 Sep; 8(9):1319-35. PubMed ID: 18694352
[TBL] [Abstract][Full Text] [Related]
12. A Single Injection of Recombinant Adeno-Associated Virus into the Lumbar Cistern Delivers Transgene Expression Throughout the Whole Spinal Cord.
Guo Y; Wang D; Qiao T; Yang C; Su Q; Gao G; Xu Z
Mol Neurobiol; 2016 Jul; 53(5):3235-3248. PubMed ID: 26050084
[TBL] [Abstract][Full Text] [Related]
13. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
14. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
[TBL] [Abstract][Full Text] [Related]
15. SV40 mediates stable gene transfer in vivo.
Strayer DS; Milano J
Gene Ther; 1996 Jul; 3(7):581-7. PubMed ID: 8818644
[TBL] [Abstract][Full Text] [Related]
16. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
[TBL] [Abstract][Full Text] [Related]
17. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
18. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
[TBL] [Abstract][Full Text] [Related]
19. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the production of recombinant SV40 vectors.
Vera M; Prieto J; Strayer DS; Fortes P
Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
